Announcements Trials
Browse Landscape

Phase

Phase 2 173Phase 1 140Phase 1/2 84Phase NA 41Phase 3 26Phase EARLY_PHASE1 6Phase 2/3 4Phase 4 2

Status

Completed 12Recruiting 9Unknown 7Terminated 4Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 21Breast 14Other hematologic neoplasm 13Genitourinary 12Lymphoid 10Gynecologic 10Head & Neck 8Dermatologic 6CNS 6Sarcoma 5Myeloid 5Plasma cell 4Tumor-Agnostic 3Other 3Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia, Myeloid 1Leukemia, B-Cell 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

fludarabine 1Whole-Body Irradiation 1Lenalidomide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Plasma cell × Clear all
NCT00967343 2021-06-14

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Kiadis Pharma

Phase 2/3 Terminated
40 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Myeloid, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02145598 2019-01-16

GERMAIN

University of Jena

Phase 2/3 Terminated
85 enrolled
Plasma cell

Multiple Myeloma

NCT00714259 2017-07-24

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

University of Alabama at Birmingham

Phase 2/3 Terminated
5 enrolled 11 charts
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, B-Cell, Lymphoma, Mantle-Cell

NCT00984828 2016-09-08

Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients

Shanghai Jiao Tong University School of Medicine

Phase 2/3 Terminated
23 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡